Roughly 800 people have developed narcolepsy after being immunized with GlaxoSmithKline's Pandemrix H1N1 flu vaccine. More
-
-
Sponsored By:
-
Sponsored By:
GSK
Flu Season: Where Investors Can Find Relief
This year's flu looks particularly troublesome, but that's good new for the many companies that benefit from flu sufferers' ills. Here's a look at some of them. More
9 Pharmaceutical Stocks to Sell Now
This week, the overall grades of nine Pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
Big Pharma: 2012-13′s Flu Vaccine Field
Here's a look at the various big pharma stocks that could see a bump from an early start to this year's flu season. More
Pharma Stock Breaking Down — Get Out Now
GlaxoSmithKline suffered a major reversal and is flashing a sell signal. Get out now. More
Biotech Movers: Regeneron Pops, 3 Flop
While Regeneron soared on behind its macular degeneration treatment, Dynavax, Navidea and AspenBio suffered serious setbacks. More
6 Pharmaceutical Stocks to Sell Now
For the current week, the overall ratings of six Pharmaceutical stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
